title: Fibrinolytic abnormalities. A Spanish multicenter study ebt.I on 443 patients with venous thromboembolic disease.
authors.affiliation: Thrombosis and Haemostasis Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
authors.forename: L
authors.initials: L
authors.lastname: Falkon
authors.forename: M
authors.initials: M
authors.lastname: Borrell
authors.forename: N
authors.initials: N
authors.lastname: Sala
authors.forename: J
authors.initials: J
authors.lastname: Felez
authors.forename: S
authors.initials: S
authors.lastname: Martín
authors.forename: E
authors.initials: E
authors.lastname: Grau
authors.forename: J
authors.initials: J
authors.lastname: Fontcuberta
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D004198:Disease Susceptibility; D005342:Fibrinolysis; D006801:Humans; D008403:Mass Screening; D008875:Middle Aged; D010958:Plasminogen / Q000032:analysis; D017395:Plasminogen Activator Inhibitor 1 / Q000032:analysis; D015995:Prevalence; D011506:Proteins / Q000032:analysis; D013030:Spain / Q000453:epidemiology; D013923:Thromboembolism / Q000097:blood* / Q000453:epidemiology / Q000209:etiology; D013924:Thrombophlebitis / Q000097:blood* / Q000453:epidemiology / Q000209:etiology; D010959:Tissue Plasminogen Activator / Q000032:analysis; D000099053:Histidine-Rich Glycoprotein
chemical_list: D017395:Plasminogen Activator Inhibitor 1; D011506:Proteins; D000099053:Histidine-Rich Glycoprotein; D010958:Plasminogen; D010959:Tissue Plasminogen Activator